New Delhi, The USA based Human Biosciences Inc (HBS) plans to launch two of its wound care management products Medifil and Skin Temp in India soon. The global biotechnology giant will introduce two of its highly demanded products with exclusive marketing and distribution channels.
The wound care management products of HBS have a huge market share in its category in India. The company has already set up a manufacturing unit in Ahmedabad and plans to increase the volume of production of these products.
Speaking on the future roadmap of the company, HBS’ founder Dr Manoj Jain said, “Our mission at HBS is to provide customers with healthcare products of high quality at an affordable price. We are planning to set up more manufacturing units in India to increase production and expand our reach so that more people can avail the benefits of these products.”
Collagen products have reconstructive properties and are meant for wound care management. Medifil and Skin Temp, considered more effecting as it helps to stop the bleeding immediately by providing faster and better wound healing. These products are most effective for diabetic patients, sever burn survivors, post pregnancy and post surgery recovery.
